Yahoo Web Search

Search results

1. • 

     Medicare Advantage unrest, Change Healthcare fallout and more big takeaways from insurers’ Q1

     Healthcare Dive via Yahoo Finance· 3 days ago

     All major payers saw elevated utilization but only an unprepared few struggled with the trend, the...

2. • Q1 2024 scPharmaceuticals Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 14 hours ago

     Steve? Steven Parsons Thank you. As John indicated, we continue to be pleased with our progress since launch. From launch in February 2023 through March 31, 2024, we had 2,184 ...

3. • Summary and Key Considerations of Recent HHS-OIG Advisory Opinion on Pharmaceutical Patient...

     JD Supra· 3 days ago

     In an unprecedent move, OIG set a time limit for the advisory opinion, terminating it two years after the full implementation of the Medicare Part

4. • What Medicare beneficiaries need to know about generic medications

     Fortune· 1 day ago

     Just ask Susan Jaquith, a retired teacher in Wilson, N.C., who’d been paying about $2,000 a year for a brand-name blood pressure medication and wanted to switch to a less ...

5. • Bipartisan bill to modernize radiation oncology re | Newswise

     Newswise· 1 day ago

     The Radiation Oncology Case...ROCR) Value-Based Payment Program Act of 2024, sponsored by Sen. Thom Tillis (R-N.C...Brian Fitzpatrick (R-Pa.), Jimmy Panetta (D< ...

6. • Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcr

     Guru Focus· 2 days ago

     For the complete transcript of the earnings call, please refer to the full earnings call transcript. Arcutis Biotherapeutics Inc (ARQT, Financial) reported strong revenue growth in Q1

7. • 

     Napa's Health Insurance Guys: Which should they choose: COBRA or Medicare?

     Napa Valley Register· 2 days ago

     Both of us will be transitioning to COBRA when I retire at the end of the month. My question is do...

8. • Harrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: R

     Guru Focus· 2 days ago

     For the complete transcript of the earnings call, please refer to the full earnings call transcript. Harrow Inc reported a 33% increase in revenues for the first quarter of 2024< ...

9. • Q1 2024 Arcutis Biotherapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 13 hours ago

     Moving to slide 10. As a reminder, the ZORYVE was approved for Seb Derm patients in mid-December 2023, with a commercial launch in late January 2024. As read, seborrheic launch ...

10. • Ten Takeaways From Long-Awaited Section 1557 Nondiscrimination Protections | JD Supra

      JD Supra· 7 days ago

      The rule, which has staggered effectivity dates starting on July 5, 2024, largely finalizes the policies as proposed in HHS’s August 2022 Notice of Proposed Rulemaking (NPRM ...